Home › NDC Lookup › RxCUI directory › RxCUI 1431682

Benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel — RxCUI 1431682

RxNorm drug concept · Semantic clinical drug
RxCUI 1431682 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1431682
Official nameBenzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % Topical Gel; benzalkonium chloride 0.13 % / lidocaine HCl 2 % Topical Gel
FDA products mapped5
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
  • What is this patch actually for — why did my doctor prescribe it?
  • You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
  • How long do I wear the patch, and can I wear more than one?
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Benzalkonium chloride 0.0013 MG/MG / lidocaine h... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel RxCUI 1431682

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Benzalkonium 1378
    • Lidocaine 6387
    • Benzalkonium / lidocaine 690077
    • Benzalkonium chloride 1379
    • Lidocaine hydrochloride 142440
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cicloferon 1431683
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzalkonium / lidocaine Topical Gel 440850
    • Benzalkonium chloride / lidocaine hydrochloride Topical Gel 2649260
    • Benzalkonium / lidocaine Topical Product 1151335
    • Benzalkonium chloride / lidocaine hydrochloride Topical Product 2660236
    • Benzalkonium / lidocaine Topical Gel [Cicloferon] 1431685
    • Benzalkonium chloride / lidocaine hydrochloride Topical Gel [Cicloferon] 2656223
    • Cicloferon Topical Product 1431686
    • Topical Gel 346286
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzalkonium chloride 0.0013 MG/MG SCDC · 1042865
  • Lidocaine hydrochloride 0.02 MG/MG SCDC · 1011799
  • Benzalkonium / lidocaine Topical Gel SCDF · 440850
  • Benzalkonium chloride / lidocaine hydrochloride Topical Gel SCDFP · 2649260
  • Benzalkonium / lidocaine Topical Product SCDG · 1151335
  • Benzalkonium chloride / lidocaine hydrochloride Topical Product SCDGP · 2660236

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 9 package NDCs
9 package NDCs map to RxCUI 1431682 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-1652-28 1 TUBE in 1 CARTON (0363-1652-28) / 28 mL in 1 TUBE Antibacterial Lidocaine Wound Gel WALGREENS 2022-12-05
51142-0652-14 1 TUBE in 1 CARTON (51142-652-14) / 14 mL in 1 TUBE Antibacterial Lidocaine Wound Gel ASO LLC 2019-10-28
51142-0652-28 1 TUBE in 1 CARTON (51142-652-28) / 28 mL in 1 TUBE Antibacterial Lidocaine Wound Gel ASO LLC 2019-10-28
59208-0002-04 1 TUBE in 1 CARTON (59208-002-04) / 4 g in 1 TUBE CICLOFERON Laboratorios Liomont, S.A. de C.V. 2019-05-01
59208-0002-05 1 TUBE in 1 CONTAINER (59208-002-05) / 4 g in 1 TUBE CICLOFERON Laboratorios Liomont, S.A. de C.V. 2019-05-01
59898-0950-01 1 TUBE in 1 CARTON (59898-950-01) / 14 mL in 1 TUBE Antibacterial Lidocaine Wound Gel Water-Jel Technologies, LLC 2019-10-28
59898-0950-02 1 TUBE in 1 CARTON (59898-950-02) / 28 mL in 1 TUBE Antibacterial Lidocaine Wound Gel Water-Jel Technologies, LLC 2019-10-28
69842-0652-14 1 TUBE in 1 CARTON (69842-652-14) / 14 mL in 1 TUBE Antibacterial Lidocaine Wound Gel CVS Pharmacy 2019-10-28
69842-0652-28 1 TUBE in 1 CARTON (69842-652-28) / 28 mL in 1 TUBE Antibacterial Lidocaine Wound Gel CVS Pharmacy 2019-10-28
Observed labelers: ASO LLC (2) · CVS Pharmacy (2) · Laboratorios Liomont, S.A. de C.V. (2) · Water-Jel Technologies, LLC (2) · WALGREENS (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.